ResearcherColumbia UniversityActive in the last 2 years
Masaki Sunagawa
Matched on ORCID iD 0000-0002-8334-1964; OpenAlex author ID A5085008523. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers
Papers 8
- Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic cancer: a prospective comparative cohort t… Co-author DOI 10.1016/j.hpb.2025.07.015↗
- FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (G… Co-author DOI 10.1093/bjs/znaf049↗
- FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. First author DOI 10.1111/cas.70212↗
- Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. Co-author DOI 10.1002/cam4.7395↗
- Antitumor Effects of Deep Ultraviolet Irradiation for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.16198↗
- Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.16245↗
- Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Co-author DOI 10.1136/gutjnl-2019-319912↗
- Trefoil factor family 1 expression in the invasion front is a poor prognostic factor associated with lymph node metastasis in pancreatic cancer. Co-author DOI 10.1016/j.pan.2017.07.188↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Junpei Yamaguchi · 7 shared papers, 2017–2025 · strength 1.26
- Paper FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. DOI 10.1111/cas.70212↗
- Paper Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic ca… DOI 10.1016/j.hpb.2025.07.015↗
- Paper Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. DOI 10.1002/cam4.7395↗
- Tomoki Ebata · 7 shared papers, 2017–2025 · strength 1.26
- Paper FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. DOI 10.1111/cas.70212↗
- Paper Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic ca… DOI 10.1016/j.hpb.2025.07.015↗
- Paper Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. DOI 10.1002/cam4.7395↗
- Toshio Kokuryo · 6 shared papers, 2017–2025 · strength 1.04
- Paper FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. DOI 10.1111/cas.70212↗
- Paper Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. DOI 10.1002/cam4.7395↗
- Paper FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic ca… DOI 10.1093/bjs/znaf049↗
- Shunsuke Onoe · 5 shared papers, 2023–2025 · strength 0.99
- Paper FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. DOI 10.1111/cas.70212↗
- Paper Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic ca… DOI 10.1016/j.hpb.2025.07.015↗
- Paper Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. DOI 10.1002/cam4.7395↗
- Yukihiro Yokoyama · 5 shared papers, 2017–2025 · strength 0.82
- Paper Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic ca… DOI 10.1016/j.hpb.2025.07.015↗
- Paper Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. DOI 10.1002/cam4.7395↗
- Paper Antitumor Effects of Deep Ultraviolet Irradiation for Pancreatic Cancer. DOI 10.21873/anticanres.16198↗
- Shoji Kawakatsu · 2 shared papers, 2025 · strength 0.47
- Paper FAM111B Suppression Enhances Sensitivity to Gemcitabine in Pancreatic Cancer Through Intracellular pH Regulation. DOI 10.1111/cas.70212↗
- Paper Close correlation between patients' positive mood and postoperative complication burden in hepato-biliary-pancreatic ca… DOI 10.1016/j.hpb.2025.07.015↗
- Taisuke Baba · 2 shared papers, 2023–2025 · strength 0.40
- Kimitoshi Yamazaki · 2 shared papers, 2023 · strength 0.31
- Masato Nagino · 2 shared papers, 2023 · strength 0.31
- Motonobu Nishimura · 1 shared paper, 2025 · strength 0.25
- Tomohisa Otsu · 1 shared paper, 2025 · strength 0.20
- Masaya Suenaga · 1 shared paper, 2025 · strength 0.20
- Haruyoshi Tanaka · 1 shared paper, 2025 · strength 0.20
- Nobuhiko Nakagawa · 1 shared paper, 2025 · strength 0.20
- Mina Fukasawa · 1 shared paper, 2025 · strength 0.20
- Yasuhiro Kodera · 1 shared paper, 2025 · strength 0.20
- Tsutomu Fujii · 1 shared paper, 2025 · strength 0.20
- Mikiko Kano Takebayashi · 1 shared paper, 2023 · strength 0.15
- Alina Cornelia Iuga · 1 shared paper, 2021 · strength 0.11
- Takayuki Tanaka · 1 shared paper, 2021 · strength 0.11
- Marina Macchini · 1 shared paper, 2021 · strength 0.11
- Ryota Takahashi · 1 shared paper, 2021 · strength 0.11
- Bernhard Willibald Renz · 1 shared paper, 2021 · strength 0.11
- Ruth Aroon White · 1 shared paper, 2021 · strength 0.11
- Tamas A. Gonda · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.